International Journal of High Risk Behaviors and Addiction

Published by: Kowsar

Modafinil for Treatment of amphetamine/ Methamphetamine Dependence: The Randomized Double - Blined ClinicaL Trial

Maryam Lashkaripour 1 , Amir Adibi 2 , * , Farzaneh Farajian Mashhadi 3 and Alireza Dashipour 4
Authors Information
1 Department of Psychiatry and Psychology, Baharan Psychiatric Hospital, Zahedan University of Medical Sciences, Zahedan, IR Iran
2 Psychiatrist, Ilam University of Medical Sciences, Ilam, IR Iran
3 Department of Pharmacology, School of Medicine, Zahedan University of Medical Sciences, Zahedan, IR Iran
4 Department of Nutrition, School of Medicine, Zahedan University of Medical Sciences, Zahedan, IR Iran
Article information
  • International Journal of High Risk Behaviors and Addiction: June 2017, 6 (2); e37660
  • Published Online: October 16, 2016
  • Article Type: Research Article
  • Received: March 7, 2016
  • Revised: June 13, 2016
  • Accepted: June 17, 2016
  • DOI: 10.5812/ijhrba.37660

To Cite: Lashkaripour M, Adibi A, Farajian Mashhadi F, Dashipour A. Modafinil for Treatment of amphetamine/ Methamphetamine Dependence: The Randomized Double - Blined ClinicaL Trial, Int J High Risk Behav Addict. 2017 ;6(2):e37660. doi: 10.5812/ijhrba.37660.

Abstract
Copyright © 2016, Zahedan University of Medical Sciences. This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.
1. Background
2. Objectives
3. Patients and Methods
4. Results
5. Discussion
Acknowledgements
Footnote
References
  • 1. Rezaei F, Emami M, Zahed S, Morabbi MJ, Farahzadi M, Akhondzadeh S. Sustained-release methylphenidate in methamphetamine dependence treatment: a double-blind and placebo-controlled trial. Daru. 2015; 23: 2[DOI][PubMed]
  • 2. Alemikhah M, Faridhosseini F, Kordi H, Rasouli-Azad M, Shahini N. Comparative Study of the Activity of Brain Behavioral Systems in Methamphetamine and Opiate Dependents. Int J High Risk Behav Addict. 2016; 5(1): 25075[DOI][PubMed]
  • 3. lashkaripour K, Torbati E. Methamphetamine dependency. Int J High Risk Behav Addict. 2012; 1(1): 7-8[DOI]
  • 4. Alam-Mehrjerdi Z, Mokri A, Dolan K. Methamphetamine use and treatment in Iran: A systematic review from the most populated Persian Gulf country. Asian J Psychiatr. 2015; 16: 17-25[DOI]
  • 5. lashkaripour K, Usefi M, Ghasemi S, Zabihi R. The comparison of demographic characteristics and variety of substances in Methadone maintenance clinic of Baharan Psychiatry Hospital in 1388-1390. 124;
  • 6. Ekhtiari H, Alam-Mehrjerdi Z, Hassani-Abharian P, Nouri M, Farnam R, Mokri A. Examination and Evaluation of Craving-Inductive Verbal Cues among Persian-Speaking Methamphetamine Abusers. 2010; 12(2)
  • 7. Sadock BJ. Sadock, Virginia Alcott, Kaplan & Sadock's Synopsis of Psychiatry: Behavioral Sciences/Clinical Psychiatry. 2015; : 674
  • 8. Simon SL, Domier C, Carnell J, Brethen P, Rawson R, Ling W. Cognitive impairment in individuals currently using methamphetamine. Am J Addict. 2000; 9(3): 222-31[PubMed]
  • 9. Chen H, Wu J, Zhang J, Hashimoto K. Recent topics on pharmacotherapy for amphetamine-type stimulants abuse and dependence. Curr Drug Abuse Rev. 2010; 3(4): 222-38[PubMed]
  • 10. Izadi-Mood N, Tavahen N, Masoumi GR, Gheshlaghi F, Dana Siadat Z, Setareh M, et al. Demographic Factors, Duration of Hospitalization, Costs of Hospitalization, and Cause of Death in Patients Intoxicated with Amphetamines and Opioids. J Isfahan Med School. 2011; 29(146)
  • 11. Newton TF, Kalechstein AD, Duran S, Vansluis N, Ling W. Methamphetamine abstinence syndrome: preliminary findings. Am J Addict. 2004; 13(3): 248-55[DOI][PubMed]
  • 12. Karila L, Weinstein A, Aubin HJ, Benyamina A, Reynaud M, Batki SL. Pharmacological approaches to methamphetamine dependence: a focused review. Br J Clin Pharmacol. 2010; 69(6): 578-92[DOI][PubMed]
  • 13. Anderson AL, Li SH, Biswas K, McSherry F, Holmes T, Iturriaga E, et al. Modafinil for the treatment of methamphetamine dependence. Drug Alcohol Depend. 2012; 120(1-3): 135-41[DOI][PubMed]
  • 14. Heinzerling KG, Swanson AN, Kim S, Cederblom L, Moe A, Ling W, et al. Randomized, double-blind, placebo-controlled trial of modafinil for the treatment of methamphetamine dependence. Drug Alcohol Depend. 2010; 109(1-3): 20-9[DOI][PubMed]
  • 15. Shearer J, Darke S, Rodgers C, Slade T, van Beek I, Lewis J, et al. A double-blind, placebo-controlled trial of modafinil (200 mg/day) for methamphetamine dependence. Addiction. 2009; 104(2): 224-33[DOI][PubMed]
  • 16. Hester R, Lee N, Pennay A, Nielsen S, Ferris J. The effects of modafinil treatment on neuropsychological and attentional bias performance during 7-day inpatient withdrawal from methamphetamine dependence. Exp Clin Psychopharmacol. 2010; 18(6): 489-97[DOI]
  • 17. Sintonen H. The 15D instrument of health-related quality of life: properties and applications. Ann Med. 2001; 33(5): 328-36[PubMed]
  • 18. Gossop M, Darke S, Griffiths P, Hando J, Powis B, Hall W. The Severity of Dependence Scale (SDS): psychometric properties of the SDS in English and Australian samples of heroin, cocaine and amphetamine users. Addiction. 1995; 90: 607-14[DOI]
  • 19. Vazirian M, Mostashari G. 2002; : 55
  • 20. Thompson DG, Kesler SR, Sudheimer K, Mehta KM, Thompson LW, Marquett RM, et al. fMRI Activation During Executive Function Predicts Response to Cognitive Behavioral Therapy in Older, Depressed Adults. Am J Geriatr Psychiatr. 2014; 14: 1064-7481
  • 21. Miles SW, Sheridan J, Russell B, Kydd R, Wheeler A, Walters C, et al. Extended-release methylphenidate for treatment of amphetamine/methamphetamine dependence: a randomized, double-blind, placebo-controlled trial. Addiction. 2013; 108(7): 1279-86[DOI][PubMed]
  • 22. Gonzalez B, Raineri M, Cadet JL, Garcia-Rill E, Urbano FJ, Bisagno V. Modafinil improves methamphetamine-induced object recognition deficits and restores prefrontal cortex ERK signaling in mice. Neuropharmacology. 2014; 87: 188-97[DOI][PubMed]
Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .

Search Relations:

Author(s):

Article(s):

Create Citiation Alert
via Google Reader

Readers' Comments